Medroxyprogesterone 30mg Tablets

Medroxyprogesterone Acetate SR 30 mg Tablets contain medroxyprogesterone acetate, a synthetic progestogen used in the management of selected hormone-related conditions. The SR formulation is designed to provide sustained release of the active ingredient.

According to the relevant product labeling, this 30 mg sustained-release formulation is indicated for mild-to-moderate endometriosis. Treatment should be prescribed and monitored by a qualified healthcare professional.

Product Information

Product Name

Medroxyprogesterone Acetate SR 30 mg Tablets

Active Ingredient

Medroxyprogesterone acetate

Strength

30 mg per tablet

Dosage Form

Sustained-release oral tablet

Drug Class

Progestogen (progestin)

Route of Administration

Oral

Indication

Mild-to-moderate endometriosis, according to the relevant product labeling

Pack Size

Confirm available packaging

Manufacturer

Verify the product label

Prescription Requirement

Subject to local regulations

Ordering and Availability

For Medroxyprogesterone Acetate SR 30 mg tablet pricing, pack sizes and availability, contact the supplier to confirm the exact formulation, manufacturer, packaging and current stock.

Availability, product authorization, prescription requirements and import eligibility vary by country. Verify local regulations and obtain the medicine through an authorized pharmacy or eligible supplier.

Medroxyprogesterone acetate affects progesterone-related pathways involved in reproductive and menstrual function.

The relevant 30 mg sustained-release product labeling indicates use for:

• Mild-to-Moderate Endometriosis: Prescribed treatment for selected patients with endometriosis.
• Hormonal Management: Provides progestogenic activity as part of the prescribed treatment plan.

The suitability of this formulation depends on the diagnosis, product authorization and individual medical assessment.

Take Medroxyprogesterone Acetate SR 30 mg Tablets only as prescribed by your healthcare professional. The treatment schedule and duration depend on the diagnosed condition and the instructions for the specific product.

Swallow the tablet according to its package instructions. Do not crush, chew or split a sustained-release tablet unless the product leaflet or pharmacist specifically confirms that this is permitted.

Do not change the dose or discontinue treatment without medical advice.

Storage Instructions

Store the tablets according to the manufacturer's instructions on the packaging or patient information leaflet. Keep the medicine out of the reach of children and do not use it after the stated expiry date.

Possible adverse effects may include:

• Headache or dizziness
• Nausea or abdominal discomfort
• Breast tenderness
• Changes in menstrual bleeding or spotting
• Mood changes
• Fluid retention or weight changes

Seek urgent medical attention for chest pain, sudden shortness of breath, one-sided leg swelling, a severe sudden headache or sudden changes in vision or speech.

Inform your healthcare professional about your medical history, current medicines and any possibility of pregnancy before starting treatment.

Medroxyprogesterone acetate may be unsuitable for people with certain hormone-sensitive cancers, unexplained genital bleeding, active or previous thromboembolic disease, significant liver disease or known or suspected pregnancy.

Discuss any history of cardiovascular disease, migraines or other relevant medical conditions with your prescriber. Follow the specific product leaflet for the complete list of contraindications, warnings and precautions.